Skip to main content
Galapagos NV logo

Galapagos NV — Investor Relations & Filings

Ticker · GLPG ISIN · BE0003818359 LEI · 549300QKJ78IY0IOV655 BR Manufacturing
Open in API
Filings indexed 2,862 across all filing types
Latest filing 2024-05-16 Share Issue/Capital Cha…
Country BE Belgium
Listing BR GLPG

About Galapagos NV

https://www.glpg.com/

Galapagos NV is a biotechnology company focused on transforming patient outcomes through scientific innovation. The company is strategically concentrating its efforts on its cell therapy platform, which is engineered for the scalable, decentralized, and rapid production of next-generation treatments. A key feature of this platform is a median 7-day vein-to-vein delivery time. In parallel with this focus, Galapagos is actively seeking partners to take over its portfolio of small molecule assets, including its TYK2 inhibitor program for autoimmune indications. This strategic shift allows the company to prioritize the growth and development of its cell therapy pipeline through internal discovery, partnerships, and acquisitions.

Recent filings

Filing Released Lang Actions
press-release-subscription-right-plans-2024-nl.pdf
Share Issue/Capital Change Classification · 99% confidence The document text is an announcement from Galapagos NV regarding the creation of new subscription rights plans ('inschrijvingsrechtenplannen') for employees. This action directly relates to the company's capital structure, specifically the issuance of rights that can lead to new shares. This falls under the definition of Capital/Financing Update (CAP), as it details the creation of instruments affecting potential future share capital. It is not a full financial report (10-K or IR), an earnings release (ER), or a dividend notice (DIV). The core subject is the creation of new rights tied to employee compensation/incentives, which is a capital structure event.
2024-05-16 Dutch
6-K Filing
Regulatory Filings
2024-05-16 English
6-K Filing
Regulatory Filings
2024-05-16 English
Galapagos reports first quarter 2024 financial results
Interim / Quarterly Report Classification · 100% confidence The document is a detailed financial report for the first quarter of 2024, titled 'Galapagos reports first quarter 2024 financial results'. It contains comprehensive financial statements, including consolidated income statements, balance sheet data, and detailed breakdowns of operating expenses, revenues, and net profit for the period ending 31 March 2024. It is not a mere announcement or certification, but a substantive financial report, fitting the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-05-03 English
Galapagos reports first quarter 2024 financial results
Earnings Release Classification · 100% confidence The document explicitly states in the title and opening paragraph that it reports 'financiële resultaten voor het eerste kwartaal 2024' (financial results for the first quarter of 2024). It contains detailed financial tables comparing Q1 2024 results with Q1 2023 results, covering revenue, R&D costs, net profit/loss, and cash position. This structure is characteristic of a comprehensive periodic financial report covering a period shorter than a year. The appropriate classification is Interim / Quarterly Report (IR). It is not an Earnings Release (ER) because it is a detailed report, not just the initial highlights, and it is not a 10-K as it covers only one quarter. Q1 2024
2024-05-03 Dutch
6-K Filing
Regulatory Filings
2024-05-03 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.